Drug General Information
Drug ID
D0F6IV
Former ID
DNC000697
Drug Name
Glycyrrhetinic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535709]
Structure
Download
2D MOL

3D MOL

Formula
C30H46O4
Canonical SMILES
CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(<br />=O)O)C)C)C)C
InChI
1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1
InChIKey
MPDGHEJMBKOTSU-YKLVYJNSSA-N
CAS Number
CAS 471-53-4
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:30853
SuperDrug ATC ID
D03AX10
SuperDrug CAS ID
cas=000471534
Target and Pathway
Target(s) Corticosteroid 11-beta-dehydrogenase, isozyme 2 Target Info Inhibitor [535709]
KEGG Pathway Steroid hormone biosynthesis
Aldosterone-regulated sodium reabsorption
NetPath Pathway EGFR1 Signaling Pathway
PathWhiz Pathway Steroidogenesis
Reactome Glucocorticoid biosynthesis
WikiPathways Prostaglandin Synthesis and Regulation
Glucocorticoid & Mineralcorticoid Metabolism
References
Ref 535709Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene. 2003 Mar 20;22(11):1663-7.
Ref 535709Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene. 2003 Mar 20;22(11):1663-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.